• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SelectQuote, Inc. Reports First Quarter of Fiscal Year 2025 Results

    11/4/24 7:30:00 AM ET
    $SLQT
    Specialty Insurers
    Finance
    Get the next $SLQT alert in real time by email

    First Quarter of Fiscal Year 2025 – Consolidated Earnings Highlights

    • Revenue of $292.3 million
    • Net loss of $44.5 million
    • Adjusted EBITDA* of $(1.7) million

    Fiscal Year 2025 Guidance Ranges:

    • Revenue expected in a range of $1.425 billion to $1.525 billion
    • Net income (loss) expected in a range of $(59) million to $3 million
    • Adjusted EBITDA* expected in a range of $100 million to $130 million

    First Quarter Fiscal Year 2025 – Segment Highlights

    Senior

    • Revenue of $92.9 million
    • Adjusted EBITDA* of $7.7 million
    • Approved Medicare Advantage policies of 91,680

    Healthcare Services

    • Revenue of $155.7 million
    • Adjusted EBITDA* of $4.9 million
    • 86,521 SelectRx members

    Life

    • Revenue of $39.3 million
    • Adjusted EBITDA* of $6.0 million

    SelectQuote, Inc. (NYSE:SLQT) reported consolidated revenue for the first quarter of fiscal year 2025 of $292.3 million compared to consolidated revenue for the first quarter of fiscal year 2024 of $232.7 million. Consolidated net loss for the first quarter of fiscal year 2025 was $44.5 million compared to consolidated net loss for the first quarter of fiscal year 2024 of $31.1 million. Finally, consolidated Adjusted EBITDA* for the first quarter of fiscal year 2025 was $(1.7) million compared to consolidated Adjusted EBITDA* for the first quarter of fiscal year 2024 of $(11.4) million.

    SelectQuote Chief Executive Officer, Tim Danker, remarked, "SelectQuote opened our fiscal 2025 with a strong quarter and our holistic approach to healthcare connectivity between Americans in need of care, and the insurers and caregivers that provide it, has never been more valuable. As reported in the market, benefit coverage for Medicare Advantage plans shifted significantly this season, and we are pleased to say that both seniors and insurance carriers have increasingly turned to SelectQuote's agent-led, true-choice platform to ensure individual care needs are met with the best plan available. When our customers and carrier partners benefit, so do our performance metrics and shareholders, and we proud of this alignment."

    Mr. Danker continued, "This quarter was also a success for our broadening Healthcare Services platform led by SelectRx. Our bespoke prescription drug service now has over 86 thousand members, which represents growth of over 64% compared to a year ago. Separately, SelectQuote recently announced our initial receivable securitization, which was a critical first step in our ongoing strategy to improve our capital flexibility."

    "We look forward to sharing our AEP results next quarter and are excited by the value our differentiated model continues to provide to a large and growing population of American seniors," Mr. Danker concluded.

    * See "Non-GAAP Financial Measures" below.

    Segment Results

    We currently have three reportable segments: 1) Senior, 2) Healthcare Services and 3) Life. The performance measures of the segments include total revenue and Adjusted EBITDA.* Costs of commissions and other services revenue, cost of goods sold-pharmacy revenue, marketing and advertising, selling, general, and administrative, and technical development operating expenses that are directly attributable to a segment are reported within the applicable segment. Indirect costs of revenue, marketing and advertising, selling, general, and administrative, and technical development operating expenses are allocated to each segment based on varying metrics such as headcount. Adjusted EBITDA is our segment profit measure to evaluate the operating performance of our business. We define Adjusted EBITDA as net loss plus: (i) interest expense, net; (ii) expense (benefit) for income taxes; (iii) depreciation and amortization; (iv) share-based compensation; (v) goodwill, long-lived asset, and intangible assets impairments; (vi) transaction costs; (vii) loss on disposal of property, equipment and software, net; and (viii) other non-recurring expenses and income. Adjusted EBITDA Margin is calculated as Adjusted EBITDA divided by revenue.

    Senior

    Financial Results

    The following table provides the financial results for the Senior segment for the periods presented:

    (in thousands)

     

    1Q 2025

     

     

     

    1Q 2024

     

     

    % Change

    Revenue

    $

    92,908

     

     

    $

    89,918

     

     

    3

    %

    Adjusted EBITDA*

     

    7,724

     

     

     

    (1,335

    )

     

    679

    %

    Adjusted EBITDA Margin*

     

    8

    %

     

     

    (1

    )%

     

     

    Operating Metrics

    Submitted Policies

    Submitted policies are counted when an individual completes an application with our licensed agent and provides authorization to the agent to submit the application to the insurance carrier partner. The applicant may have additional actions to take before the application will be reviewed by the insurance carrier.

    The following table shows the number of submitted policies for the periods presented:

     

    1Q 2025

     

    1Q 2024

     

    % Change

    Medicare Advantage

    102,281

     

    104,532

     

    (2

    )%

    All other (1)

    16,256

     

    14,920

     

    9

    %

    Total

    118,537

     

    119,452

     

    (1

    )%

    (1) Represents the submitted policies for medicare supplement, dental, vision and hearing, prescription drug plan and other.

    Approved Policies

    Approved policies represents the number of submitted policies that were approved by our insurance carrier partners for the identified product during the indicated period. Not all approved policies will go in force.

    * See "Non-GAAP Financial Measures" below.

    The following table shows the number of approved policies for the periods presented:

     

    1Q 2025

     

    1Q 2024

     

    % Change

    Medicare Advantage

    91,680

     

    97,681

     

    (6

    )%

    All other (1)

    12,979

     

    12,195

     

    6

    %

    Total

    104,659

     

    109,876

     

    (5

    )%

    (1) Represents the approved policies for medicare supplement, dental, vision and hearing, prescription drug plan and other.

    Lifetime Value of Commissions per Approved Policy

    Lifetime value of commissions per approved policy represents commissions estimated to be collected over the estimated life of an approved policy based on multiple factors, including but not limited to, contracted commission rates, carrier mix and expected policy persistency with applied constraints. The lifetime value of commissions per approved policy is equal to the sum of the commission revenue due upon the initial sale of a policy, and when applicable, an estimate of future renewal commissions.

    The following table shows the lifetime value of commissions per approved policy for the periods presented:

    (dollars per policy):

     

    1Q 2025

     

     

    1Q 2024

     

    % Change

    Medicare Advantage

    $

    812

     

    $

    761

     

    7

    %

    All other (1)

     

    165

     

     

    164

     

    —

    %

    (1) Represents the weighted average LTV per approved policy.

    Healthcare Services

    Financial Results

    The following table provides the financial results for the Healthcare Services segment for the periods presented:

    (in thousands)

     

    1Q 2025

     

     

     

    1Q 2024

     

     

    % Change

    Revenue

    $

    155,739

     

     

    $

    97,368

     

     

    60

    %

    Adjusted EBITDA*

     

    4,878

     

     

     

    2,322

     

     

    110

    %

    Adjusted EBITDA Margin*

     

    3

    %

     

     

    2

    %

     

     

    Operating Metrics

    Members

    The total number of SelectRx members represents the amount of active customers to which an order has been shipped and the prescriptions per day represents the total average prescriptions shipped per business day. These two metrics are the primary drivers of revenue for Healthcare Services.

    The following table shows the total number of SelectRx members as of the periods presented:

     

     

    September 30, 2024

     

    September 30, 2023

    Total SelectRx Members

     

    86,521

     

    52,750

    The total number of SelectRx members increased by 64% as of September 30, 2024, compared to September 30, 2023, due to our continued operating strategy to grow SelectRx.

    * See "Non-GAAP Financial Measures" below.

    The following table shows the average prescriptions shipped per day for the periods presented:

     

     

    September 30, 2024

     

    September 30, 2023

    Prescriptions Per Day

     

    24,998

     

    15,479

    Combined Senior and Healthcare Services - Consumer Per Unit Economics

    The opportunity to leverage our existing database and distribution model to improve access to healthcare services for our consumers has created a need for us to review our key metrics related to our per unit economics. As we think about the revenue and expenses for Healthcare Services, we note that they are derived from the marketing acquisition costs associated with the sale of an MA or MS policy, some of which costs are allocated directly to Healthcare Services, and therefore determined that our per unit economics measure should include components from both Senior and Healthcare Services. See details of revenue and expense items included in the calculation below.

    Combined Senior and Healthcare Services consumer per unit economics represents total MA and MS commissions; other product commissions; other revenues, including revenues from Healthcare Services; and operating expenses associated with Senior and Healthcare Services, each shown per number of approved MA and MS policies over a given time period. Management assesses the business on a per-unit basis to help ensure that the revenue opportunity associated with a successful policy sale is attractive relative to the marketing acquisition cost. Because not all acquired leads result in a successful policy sale, all per-policy metrics are based on approved policies, which is the measure that triggers revenue recognition.

    The MA and MS commission per MA/MS policy represents the LTV for policies sold in the period. Other commission per MA/MS policy represents the LTV for other products sold in the period, including DVH prescription drug plan, and other products, which management views as additional commission revenue on our agents' core function of MA/MS policy sales. Pharmacy revenue per MA/MS policy represents revenue from SelectRx, and other revenue per MA/MS policy represents revenue from Population Health, production bonuses, marketing development funds, lead generation revenue, and adjustments from the Company's reassessment of its cohorts' transaction prices. Total operating expenses per MA/MS policy represents all of the operating expenses within Senior and Healthcare Services. The revenue to customer acquisition cost ("CAC") multiple represents total revenue as a multiple of total marketing acquisition cost, which represents the direct costs of acquiring leads. These costs are included in marketing and advertising expense within the total operating expenses per MA/MS policy.

    The following table shows combined Senior and Healthcare Services consumer per unit economics for the periods presented. Based on the seasonality of Senior and the fluctuations between quarters, we believe that the most relevant view of per unit economics is on a rolling 12-month basis. All per MA/MS policy metrics below are based on the sum of approved MA/MS policies, as both products have similar commission profiles.

     

    Twelve Months Ended September 30,

    (dollars per approved policy):

     

    2025

     

     

     

    2024

     

    MA and MS approved policies

     

    621,040

     

     

     

    594,554

     

    MA and MS commission per MA / MS policy

    $

    919

     

     

    $

    872

     

    Other commission per MA/MS policy

     

    12

     

     

     

    13

     

    Pharmacy revenue per MA/MS policy

     

    842

     

     

     

    493

     

    Other revenue per MA/MS policy

     

    152

     

     

     

    151

     

    Total revenue per MA / MS policy

     

    1,925

     

     

     

    1,529

     

    Total operating expenses per MA / MS policy

     

    (1,626

    )

     

     

    (1,278

    )

    Adjusted EBITDA per MA/MS policy *

    $

    299

     

     

    $

    251

     

    Adjusted EBITDA Margin per MA/MS policy *

     

    16

    %

     

     

    16

    %

    Revenue / CAC multiple

    4.6X

     

    4.3X

    Total revenue per MA/MS policy increased 26% for the twelve months ended September 30, 2024, compared to the twelve months ended September 30, 2023, primarily due to the increase in pharmacy revenue. Total operating expenses per MA/MS policy increased 27% for the twelve months ended September 30, 2024, compared to the twelve months ended September 30, 2023, driven by an increase in cost of goods sold-pharmacy revenue for Healthcare Services due to the growth of the business.

    Life

    Financial Results

    The following table provides the financial results for the Life segment for the periods presented:

    (in thousands)

     

    1Q 2025

     

     

     

    1Q 2024

     

     

    % Change

    Revenue

    $

    39,290

     

     

    $

    37,803

     

     

    4

    %

    Adjusted EBITDA*

     

    5,960

     

     

     

    5,240

     

     

    14

    %

    Adjusted EBITDA Margin*

     

    15

    %

     

     

    14

    %

     

     

    Operating Metrics

    Life premium represents the total premium value for all policies that were approved by the relevant insurance carrier partner and for which the policy document was sent to the policyholder and payment information was received by the relevant insurance carrier partner during the indicated period. Because our commissions are earned based on a percentage of total premium, total premium volume for a given period is the key driver of revenue for our Life segment.

    The following table shows term and final expense premiums for the periods presented:

    (in thousands)

     

    1Q 2025

     

     

    1Q 2024

     

    % Change

    Term Premiums

    $

    15,218

     

    $

    18,190

     

    (16

    )%

    Final Expense Premiums

     

    24,473

     

     

    19,699

     

    24

    %

    Total

    $

    39,691

     

    $

    37,889

     

    5

    %

    * See "Non-GAAP Financial Measures" below.

    Earnings Conference Call

    SelectQuote, Inc. will host a conference call with the investment community on November 4, 2024, beginning at 8:30 a.m. ET. To register for this conference call, please use this link: https://registrations.events/direct/Q4I1559258472. After registering, a confirmation will be sent via email, including dial-in details and unique conference call codes for entry. Registration is open through the live call, but to ensure you are connected for the full call we suggest registering at least 10 minutes before the start of the call. The event will also be webcasted live via our investor relations website https://ir.selectquote.com/investor-home/default.aspx.

    Non-GAAP Financial Measures

    This release includes certain non-GAAP financial measures intended to supplement, not substitute for, comparable GAAP measures. To supplement our financial statements presented in accordance with GAAP and to provide investors with additional information regarding our GAAP financial results, we have presented in this release Adjusted EBITDA and Adjusted EBITDA Margin, which are non-GAAP financial measures. These non-GAAP financial measures are not based on any standardized methodology prescribed by GAAP and are not necessarily comparable to similarly titled measures presented by other companies. We define Adjusted EBITDA as net income (loss) before interest expense, income tax expense (benefit), depreciation and amortization, and certain add-backs for non-cash or non-recurring expenses, including restructuring and share-based compensation expenses. The most directly comparable GAAP measure is net income (loss). We define Adjusted EBITDA Margin as Adjusted EBITDA divided by revenue. The most directly comparable GAAP measure is net income margin. We monitor and have presented in this release Adjusted EBITDA and Adjusted EBITDA Margin because they are key measures used by our management and Board of Directors to understand and evaluate our operating performance, to establish budgets, and to develop operational goals for managing our business. In particular, we believe that excluding the impact of these expenses in calculating Adjusted EBITDA can provide a useful measure for period-to-period comparisons of our core operating performance. We believe that these non-GAAP financial measures help identify underlying trends in our business that could otherwise be masked by the effect of the expenses that we exclude in the calculations of these non-GAAP financial measures. Accordingly, we believe that these financial measures provide useful information to investors and others in understanding and evaluating our operating results, enhancing the overall understanding of our past performance and future prospects. Reconciliations of net income (loss) to Adjusted EBITDA are presented below beginning on page 13.

    Forward Looking Statements

    This release contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as "may," "should," "could," "predict," "potential," "believe," "will likely result," "expect," "continue," "will," "anticipate," "seek," "estimate," "intend," "plan," "projection," "would" and "outlook," or the negative version of those words or other comparable words or phrases of a future or forward-looking nature. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about our industry, management's beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements.

    There are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including, but not limited to, the following: impacts of the COVID-19 pandemic and any other significant public health events; our reliance on a limited number of insurance carrier partners and any potential termination of those relationships or failure to develop new relationships; existing and future laws and regulations affecting the health insurance market; changes in health insurance products offered by our insurance carrier partners and the health insurance market generally; insurance carriers offering products and services directly to consumers; changes to commissions paid by insurance carriers and underwriting practices; competition with brokers, exclusively online brokers and carriers who opt to sell policies directly to consumers; competition from government-run health insurance exchanges; developments in the U.S. health insurance system; our dependence on revenue from carriers in our senior segment and downturns in the senior health as well as life, automotive and home insurance industries; our ability to develop new offerings and penetrate new vertical markets; risks from third-party products; failure to enroll individuals during the Medicare annual enrollment period; our ability to attract, integrate and retain qualified personnel; our dependence on lead providers and ability to compete for leads; failure to obtain and/or convert sales leads to actual sales of insurance policies; access to data from consumers and insurance carriers; accuracy of information provided from and to consumers during the insurance shopping process; cost-effective advertisement through internet search engines; ability to contact consumers and market products by telephone; global economic conditions, including inflation; disruption to operations as a result of future acquisitions; significant estimates and assumptions in the preparation of our financial statements; impairment of goodwill; our ability to regain and maintain compliance with NYSE listing standards; potential litigation and other legal proceedings or inquiries; our existing and future indebtedness; our ability to maintain compliance with our debt covenants; access to additional capital; failure to protect our intellectual property and our brand; fluctuations in our financial results caused by seasonality; accuracy and timeliness of commissions reports from insurance carriers; timing of insurance carriers' approval and payment practices; factors that impact our estimate of the constrained lifetime value of commissions per policyholder; changes in accounting rules, tax legislation and other legislation; disruptions or failures of our technological infrastructure and platform; failure to maintain relationships with third-party service providers; cybersecurity breaches or other attacks involving our systems or those of our insurance carrier partners or third-party service providers; our ability to protect consumer information and other data; failure to market and sell Medicare plans effectively or in compliance with laws; and other factors related to our pharmacy business, including manufacturing or supply chain disruptions, access to and demand for prescription drugs, and regulatory changes or other industry developments that may affect our pharmacy operations. For a further discussion of these and other risk factors that could impact our future results and performance, see the section entitled "Risk Factors" in the most recent Annual Report on Form 10-K (the "Annual Report") and subsequent periodic reports filed by us with the Securities and Exchange Commission. Accordingly, you should not place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made, and, except as otherwise required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise.

    About SelectQuote:

    Founded in 1985, SelectQuote (NYSE:SLQT) provides solutions that help consumers protect their most valuable assets: their families, health, and property. The company pioneered the model of providing unbiased comparisons from multiple, highly-rated insurance companies allowing consumers to choose the policy and terms that best meet their unique needs. Two foundational pillars underpin SelectQuote's success: a strong force of highly-trained and skilled agents who provide a consultative needs analysis for every consumer, and proprietary technology that sources and routes high-quality leads.

    With an ecosystem offering high touchpoints for consumers across Insurance, Medicare, Pharmacy, and Value-Based Care, the company now has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote Senior serves the needs of a demographic that sees around 10,000 people turn 65 each day with a range of Medicare Advantage and Medicare Supplement plans. SelectQuote Healthcare Services is comprised of the SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with best-in-class healthcare services that fit each member's unique healthcare needs. The platform improves health outcomes and lowers healthcare costs through proactive engagement and access to high-value healthcare solutions.

    Source: SelectQuote, Inc.

    SELECTQUOTE, INC. AND SUBSIDIARIES

    CONSOLIDATED BALANCE SHEETS

    (Unaudited)

    (In thousands)

     

    September 30, 2024

     

    June 30, 2024

    ASSETS

     

     

     

    CURRENT ASSETS:

     

     

     

    Cash and cash equivalents

    $

    10,444

     

     

    $

    42,690

     

    Accounts receivable, net of allowances of $10.1 million and $8.2 million, respectively

     

    99,534

     

     

     

    150,035

     

    Commissions receivable-current

     

    176,760

     

     

     

    119,871

     

    Other current assets

     

    20,144

     

     

     

    20,327

     

    Total current assets

     

    306,882

     

     

     

    332,923

     

    COMMISSIONS RECEIVABLE—Net

     

    743,024

     

     

     

    761,446

     

    PROPERTY AND EQUIPMENT—Net

     

    18,191

     

     

     

    18,973

     

    SOFTWARE—Net

     

    14,224

     

     

     

    13,978

     

    OPERATING LEASE RIGHT-OF-USE ASSETS

     

    22,591

     

     

     

    23,437

     

    INTANGIBLE ASSETS—Net

     

    9,162

     

     

     

    10,194

     

    GOODWILL

     

    29,438

     

     

     

    29,438

     

    OTHER ASSETS

     

    3,359

     

     

     

    3,519

     

    TOTAL ASSETS

    $

    1,146,871

     

     

    $

    1,193,908

     

     

     

     

     

    LIABILITIES AND SHAREHOLDERS' EQUITY

     

     

     

    CURRENT LIABILITIES:

     

     

     

    Accounts payable

    $

    51,108

     

     

    $

    36,587

     

    Accrued expenses

     

    15,409

     

     

     

    16,904

     

    Accrued compensation and benefits

     

    44,735

     

     

     

    57,594

     

    Operating lease liabilities—current

     

    4,764

     

     

     

    4,709

     

    Current portion of long-term debt

     

    43,290

     

     

     

    45,854

     

    Contract liabilities

     

    2,952

     

     

     

    8,066

     

    Other current liabilities

     

    4,487

     

     

     

    4,873

     

    Total current liabilities

     

    166,745

     

     

     

    174,587

     

    LONG-TERM DEBT, NET—less current portion

     

    637,155

     

     

     

    637,480

     

    DEFERRED INCOME TAXES

     

    46,018

     

     

     

    37,478

     

    OPERATING LEASE LIABILITIES

     

    24,560

     

     

     

    25,685

     

    OTHER LIABILITIES

     

    2,954

     

     

     

    1,877

     

    Total liabilities

     

    877,432

     

     

     

    877,107

     

     

     

     

     

    COMMITMENTS AND CONTINGENCIES

     

     

     

     

     

     

     

    SHAREHOLDERS' EQUITY:

     

     

     

    Common stock, $0.01 par value

     

    1,715

     

     

     

    1,694

     

    Additional paid-in capital

     

    580,712

     

     

     

    580,764

     

    Accumulated deficit

     

    (314,315

    )

     

     

    (269,769

    )

    Accumulated other comprehensive income

     

    1,327

     

     

     

    4,112

     

    Total shareholders' equity

     

    269,439

     

     

     

    316,801

     

    TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

    $

    1,146,871

     

     

    $

    1,193,908

     

    SELECTQUOTE, INC. AND SUBSIDIARIES

    CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

    (Unaudited)

    (In thousands)

     

    Three Months Ended September 30,

     

     

    2024

     

     

     

    2023

     

    REVENUE:

     

     

     

    Commissions and other services

    $

    139,380

     

     

    $

    137,942

     

    Pharmacy

     

    152,883

     

     

     

    94,788

     

    Total revenue

     

    292,263

     

     

     

    232,730

     

     

     

     

     

    OPERATING COSTS AND EXPENSES:

     

     

     

    Cost of commissions and other services revenue

     

    65,733

     

     

     

    72,511

     

    Cost of goods sold—pharmacy revenue

     

    129,524

     

     

     

    84,008

     

    Marketing and advertising

     

    63,764

     

     

     

    62,323

     

    Selling, general, and administrative

     

    36,145

     

     

     

    28,666

     

    Technical development

     

    9,074

     

     

     

    7,637

     

    Total operating costs and expenses

     

    304,240

     

     

     

    255,145

     

     

     

     

     

    LOSS FROM OPERATIONS

     

    (11,977

    )

     

     

    (22,415

    )

     

     

     

     

    INTEREST EXPENSE, NET

     

    (23,031

    )

     

     

    (21,397

    )

    OTHER EXPENSE, NET

     

    (12

    )

     

     

    (38

    )

    LOSS BEFORE INCOME TAX EXPENSE (BENEFIT)

     

    (35,020

    )

     

     

    (43,850

    )

    INCOME TAX EXPENSE (BENEFIT)

     

    9,526

     

     

     

    (12,799

    )

     

     

     

     

    NET LOSS

    $

    (44,546

    )

     

    $

    (31,051

    )

     

     

     

     

    NET LOSS PER SHARE:

     

     

     

    Basic

    $

    (0.26

    )

     

    $

    (0.19

    )

    Diluted

    $

    (0.26

    )

     

    $

    (0.19

    )

     

     

     

     

    WEIGHTED-AVERAGE COMMON STOCK OUTSTANDING USED IN PER SHARE AMOUNTS:

     

     

     

    Basic

     

    170,431

     

     

     

    167,453

     

    Diluted

     

    170,431

     

     

     

    167,453

     

     

     

     

     

    OTHER COMPREHENSIVE LOSS NET OF TAX:

     

     

     

    Change in cash flow hedge

     

    (2,785

    )

     

     

    (2,010

    )

    OTHER COMPREHENSIVE LOSS

     

    (2,785

    )

     

     

    (2,010

    )

    COMPREHENSIVE LOSS

    $

    (47,331

    )

     

    $

    (33,061

    )

    SELECTQUOTE, INC. AND SUBSIDIARIES

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (Unaudited)

    (In thousands)

     

     

    Three Months Ended September 30,

     

     

     

    2024

     

     

     

    2023

     

    CASH FLOWS FROM OPERATING ACTIVITIES:

     

     

     

     

    Net loss

     

    $

    (44,546

    )

     

    $

    (31,051

    )

    Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:

     

     

     

     

    —

     

    Depreciation and amortization

     

     

    5,599

     

     

     

    5,989

     

    Loss on disposal of property, equipment, and software

     

     

    68

     

     

     

    9

     

    Share-based compensation expense

     

     

    3,846

     

     

     

    3,175

     

    Deferred income taxes

     

     

    9,526

     

     

     

    (13,049

    )

    Amortization of debt issuance costs and debt discount

     

     

    1,064

     

     

     

    1,612

     

    Accrued interest payable in kind

     

     

    5,289

     

     

     

    3,622

     

    Non-cash lease expense

     

     

    903

     

     

     

    784

     

    Changes in operating assets and liabilities:

     

     

     

     

    Accounts receivable, net

     

     

    50,501

     

     

     

    38,693

     

    Commissions receivable

     

     

    (38,466

    )

     

     

    (29,148

    )

    Other assets

     

     

    (3,516

    )

     

     

    (2,027

    )

    Accounts payable and accrued expenses

     

     

    12,761

     

     

     

    5,257

     

    Operating lease liabilities

     

     

    (1,127

    )

     

     

    (1,498

    )

    Other liabilities

     

     

    (18,512

    )

     

     

    (6,039

    )

    Net cash used in operating activities

     

     

    (16,610

    )

     

     

    (23,671

    )

    CASH FLOWS FROM INVESTING ACTIVITIES:

     

     

     

     

    Purchases of property and equipment

     

     

    (442

    )

     

     

    (616

    )

    Proceeds from sales of property and equipment

     

     

    —

     

     

     

    253

     

    Purchases of software and capitalized software development costs

     

     

    (2,132

    )

     

     

    (1,782

    )

    Net cash used in investing activities

     

     

    (2,574

    )

     

     

    (2,145

    )

    CASH FLOWS FROM FINANCING ACTIVITIES:

     

     

     

     

    Payments on Term Loans

     

     

    (8,471

    )

     

     

    (8,471

    )

    Payments on other debt

     

     

    (30

    )

     

     

    (37

    )

    Proceeds from common stock options exercised and employee stock purchase plan

     

     

    38

     

     

     

    —

     

    Payments of tax withholdings related to net share settlement of equity awards

     

     

    (3,915

    )

     

     

    (346

    )

    Payments of debt issuance costs

     

     

    (684

    )

     

     

    —

     

    Net cash used in financing activities

     

     

    (13,062

    )

     

     

    (8,854

    )

    NET DECREASE IN CASH AND CASH EQUIVALENTS

     

     

    (32,246

    )

     

     

    (34,670

    )

    CASH AND CASH EQUIVALENTS—Beginning of period

     

     

    42,690

     

     

     

    83,156

     

    CASH AND CASH EQUIVALENTS—End of period

     

    $

    10,444

     

     

    $

    48,486

     

     

     

     

     

     

    SELECTQUOTE, INC. AND SUBSIDIARIES

    Adjusted EBITDA to Loss before income tax expense (benefit) Reconciliation

    (Unaudited)

     

    Three Months Ended September 30, 2024

    (in thousands)

    Senior

     

    Healthcare Services

     

    Life

     

    Total

    Adjusted Segment EBITDA

    $

    7,724

     

    $

    4,878

     

    $

    5,960

     

    $

    18,562

     

    All other Adjusted EBITDA

     

     

     

     

     

     

     

    3,797

     

    Corporate & elimination of intersegment profits

     

     

     

     

     

     

     

    (24,042

    )

    Adjusted EBITDA

     

     

     

     

     

     

     

    (1,683

    )

     

     

     

     

     

     

     

     

    Share-based compensation expense

     

     

     

     

     

     

     

    (3,846

    )

    Transaction costs (1)

     

     

     

     

     

     

     

    (826

    )

    Depreciation and amortization

     

     

     

     

     

     

     

    (5,599

    )

    Loss on disposal of property, equipment, and software, net

     

     

     

     

     

     

     

    (35

    )

    Interest expense, net

     

     

     

     

     

     

     

    (23,031

    )

    Loss before income tax expense (benefit)

     

     

     

     

     

     

    $

    (35,020

    )

     

    Three Months Ended September 30, 2023

    (in thousands)

    Senior

     

    Healthcare Services

     

    Life

     

    Total

    Adjusted Segment EBITDA

    $

    (1,335

    )

     

    $

    2,322

     

    $

    5,240

     

    $

    6,227

     

    All other Adjusted EBITDA

     

     

     

     

     

     

     

    3,319

     

    Corporate & elimination of intersegment profits

     

     

     

     

     

     

     

    (20,922

    )

    Adjusted EBITDA

     

     

     

     

     

     

     

    (11,376

    )

     

     

     

     

     

     

     

     

    Share-based compensation expense

     

     

     

     

     

     

     

    (3,175

    )

    Transaction costs (1)

     

     

     

     

     

     

     

    (1,904

    )

    Depreciation and amortization

     

     

     

     

     

     

     

    (5,989

    )

    Loss on disposal of property, equipment, and software

     

     

     

     

     

     

     

    (9

    )

    Interest expense, net

     

     

     

     

     

     

     

    (21,397

    )

    Loss before income tax expense (benefit)

     

     

     

     

     

     

    $

    (43,850

    )

    SELECTQUOTE, INC. AND SUBSIDIARIES

    Net Income (Loss) to Adjusted EBITDA Reconciliation

    (Unaudited)

    Guidance Net income (loss) to Adjusted EBITDA reconciliation, year ending June 30, 2025:

    (in thousands)

    Range

    Net income (loss)

    $

    (59,000

    )

     

    $

    3,000

    Income tax expense

     

    13,000

     

     

     

    1,000

    Interest expense, net

     

    100,000

     

     

     

    90,000

    Depreciation and amortization

     

    24,000

     

     

     

    20,000

    Share-based compensation expense

     

    16,000

     

     

     

    13,000

    Transaction costs

     

    6,000

     

     

     

    3,000

    Adjusted EBITDA

    $

    100,000

     

     

    $

    130,000

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241104387638/en/

    Get the next $SLQT alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $SLQT

    DatePrice TargetRatingAnalyst
    5/21/2025$2.75Hold
    Jefferies
    9/30/2024$4.50Buy
    Craig Hallum
    2/29/2024$5.00Outperform
    Noble Capital Markets
    4/1/2022$4.00Neutral
    Credit Suisse
    2/8/2022$9.00 → $5.00Equal Weight
    Barclays
    2/8/2022$13.00 → $3.00Sector Perform
    RBC Capital
    2/8/2022$20.00 → $4.00Overweight → Neutral
    Piper Sandler
    2/8/2022$14.00 → $4.00Outperform → Neutral
    Credit Suisse
    More analyst ratings

    $SLQT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Devine Denise L bought $14,460 worth of shares (4,000 units at $3.62), increasing direct ownership by 1% to 318,583 units (SEC Form 4)

      4 - SelectQuote, Inc. (0001794783) (Issuer)

      3/19/25 4:54:26 PM ET
      $SLQT
      Specialty Insurers
      Finance
    • SEC Form 4: Matthews Joshua Brandon bought $113,295 worth of shares (97,500 units at $1.16), increasing direct ownership by 32% to 400,937 units

      4 - SelectQuote, Inc. (0001794783) (Issuer)

      9/18/23 6:29:01 PM ET
      $SLQT
      Specialty Insurers
      Finance
    • SEC Form 4: Grant William Thomas Iii bought $179,250 worth of shares (150,000 units at $1.20), increasing direct ownership by 9% to 1,913,851 units

      4 - SelectQuote, Inc. (0001794783) (Issuer)

      9/18/23 6:28:20 PM ET
      $SLQT
      Specialty Insurers
      Finance

    $SLQT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SelectQuote Mourns the Passing of Tom Grant, Vice Chairman of the Board of Directors

      SelectQuote, Inc. (NYSE:SLQT) announced today that William Thomas (Tom) Grant II, Vice Chairman and former President of SelectQuote, passed away on July 1, 2025, following a battle with cancer. Tom was instrumental in formulating and executing SelectQuote's strategy over the past fifteen years as the business evolved from a term life insurance brokerage into a diversified insurance and rapidly-growing healthcare services business. His strategic insights and dedication were pivotal to the company's success. Tom also personally touched the lives of thousands of SelectQuote associates and their families with his wit, warmth, and ever-present smile. "Tom's mark on SelectQuote was profound a

      7/2/25 4:15:00 PM ET
      $SLQT
      Specialty Insurers
      Finance
    • SelectQuote's Highly-Satisfied Insurance Customers Award the Company a Net Promoter Score of 58, Considered "Great"

      The new achievement adds to SelectQuote Insurance Services' recent recognition in USA Today's "America's Best Customer Service" List for 2025. SelectQuote, Inc. (NYSE:SLQT) (the "Company"), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, today announced the results of its on-going Net Promoter Score (NPS) surveys of customers in its Senior Health, Life, and Auto & Home insurance businesses. SelectQuote Insurance Services' overall Net Promoter Score of 58 falls within the range considered "Great" by established NPS standards. SelectQuote CEO Tim Danker said, "For over 40 years, our highly-skilled agents have provided an outs

      5/27/25 8:00:00 AM ET
      $SLQT
      Specialty Insurers
      Finance
    • SelectQuote, Inc. Reports Third Quarter of Fiscal Year 2025 Results

      Third Quarter of Fiscal Year 2025 – Consolidated Earnings Highlights Revenue of $408.2 million Net income of $26.0 million Adjusted EBITDA* of $37.7 million Fiscal Year 2025 Guidance Ranges: Revenue expected in a range of $1.500 billion to $1.575 billion Net income (loss) expected in a range of $(1) million to $28 million Adjusted EBITDA* expected in a range of $115 million to $140 million Third Quarter Fiscal Year 2025 – Segment Highlights Senior Revenue of $169.4 million Adjusted EBITDA* of $45.7 million Approved Medicare Advantage policies of 168,001 Healthcare Services Revenue of $189.6 million Adjusted EBITDA* of $6.4 million 105,523 SelectRx members Li

      5/12/25 7:30:00 AM ET
      $SLQT
      Specialty Insurers
      Finance

    $SLQT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CHIEF OPERATING OFFICER Grant William Thomas Iii transferred by will 448,474 shares), increasing direct ownership by 20% to 2,672,050 units (SEC Form 4)

      4 - SelectQuote, Inc. (0001794783) (Issuer)

      7/3/25 9:03:53 AM ET
      $SLQT
      Specialty Insurers
      Finance
    • PRESIDENT Grant Robert Clay transferred by will 448,474 shares), increasing direct ownership by 22% to 2,464,408 units (SEC Form 4)

      4 - SelectQuote, Inc. (0001794783) (Issuer)

      7/3/25 9:03:07 AM ET
      $SLQT
      Specialty Insurers
      Finance
    • Director Devine Denise L bought $14,460 worth of shares (4,000 units at $3.62), increasing direct ownership by 1% to 318,583 units (SEC Form 4)

      4 - SelectQuote, Inc. (0001794783) (Issuer)

      3/19/25 4:54:26 PM ET
      $SLQT
      Specialty Insurers
      Finance

    $SLQT
    Leadership Updates

    Live Leadership Updates

    See more
    • SelectQuote Names Ryan Clement as Chief Financial Officer

      Clement has served as Interim CFO since May 2022 SelectQuote, Inc. (NYSE:SLQT) today announced that the Board of Directors appointed Ryan Clement, SVP of Financial Planning & Analysis, to serve as the company's Chief Financial Officer. Clement was named interim CFO in May 2022. CEO Tim Danker commented, "Over the last year, Ryan has excelled as our Interim CFO and has demonstrated both the financial acumen and leadership qualities we are looking for in the company's next permanent CFO. Ryan has played a critical role in our strategic redesign that has vastly improved SelectQuote's operating results and financial stability and positions the company to execute on our objectives in the futur

      2/22/23 8:00:00 AM ET
      $SLQT
      Specialty Insurers
      Finance

    $SLQT
    SEC Filings

    See more
    • SelectQuote Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - SelectQuote, Inc. (0001794783) (Filer)

      7/2/25 5:26:27 PM ET
      $SLQT
      Specialty Insurers
      Finance
    • SEC Form 10-Q filed by SelectQuote Inc.

      10-Q - SelectQuote, Inc. (0001794783) (Filer)

      5/12/25 4:12:38 PM ET
      $SLQT
      Specialty Insurers
      Finance
    • SelectQuote Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - SelectQuote, Inc. (0001794783) (Filer)

      5/12/25 7:33:00 AM ET
      $SLQT
      Specialty Insurers
      Finance

    $SLQT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Jefferies initiated coverage on SelectQuote with a new price target

      Jefferies initiated coverage of SelectQuote with a rating of Hold and set a new price target of $2.75

      5/21/25 8:59:27 AM ET
      $SLQT
      Specialty Insurers
      Finance
    • Craig Hallum initiated coverage on SelectQuote with a new price target

      Craig Hallum initiated coverage of SelectQuote with a rating of Buy and set a new price target of $4.50

      9/30/24 8:47:10 AM ET
      $SLQT
      Specialty Insurers
      Finance
    • Noble Capital Markets initiated coverage on SelectQuote with a new price target

      Noble Capital Markets initiated coverage of SelectQuote with a rating of Outperform and set a new price target of $5.00

      2/29/24 8:29:44 AM ET
      $SLQT
      Specialty Insurers
      Finance

    $SLQT
    Financials

    Live finance-specific insights

    See more
    • SelectQuote, Inc. Reports Third Quarter of Fiscal Year 2025 Results

      Third Quarter of Fiscal Year 2025 – Consolidated Earnings Highlights Revenue of $408.2 million Net income of $26.0 million Adjusted EBITDA* of $37.7 million Fiscal Year 2025 Guidance Ranges: Revenue expected in a range of $1.500 billion to $1.575 billion Net income (loss) expected in a range of $(1) million to $28 million Adjusted EBITDA* expected in a range of $115 million to $140 million Third Quarter Fiscal Year 2025 – Segment Highlights Senior Revenue of $169.4 million Adjusted EBITDA* of $45.7 million Approved Medicare Advantage policies of 168,001 Healthcare Services Revenue of $189.6 million Adjusted EBITDA* of $6.4 million 105,523 SelectRx members Li

      5/12/25 7:30:00 AM ET
      $SLQT
      Specialty Insurers
      Finance
    • SelectQuote to Release Fiscal Third Quarter 2025 Earnings on May 12

      SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced it will release its third quarter 2025 financial results before market open on Monday, May 12, 2025. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (May 12, 2025) at 8:30 am ET to discuss the results. To register for this conference call, please use this link: https://registrations.events/direct/Q4I54780976. After registering, a confirmation will be sent via email, including dial in details and unique conference call codes for entry. Registratio

      5/5/25 8:00:00 AM ET
      $SLQT
      Specialty Insurers
      Finance
    • SelectQuote, Inc. Reports Second Quarter of Fiscal Year 2025 Results

      Second Quarter of Fiscal Year 2025 – Consolidated Earnings Highlights Revenue of $481.1 million Net income of $53.2 million Adjusted EBITDA* of $87.5 million Fiscal Year 2025 Guidance Ranges: Revenue expected in a range of $1.500 billion to $1.575 billion Net income (loss) expected in a range of $(24) million to $11 million Adjusted EBITDA* expected in a range of $115 million to $140 million Second Quarter Fiscal Year 2025 – Segment Highlights Senior Revenue of $255.6 million Adjusted EBITDA* of $100.5 million Approved Medicare Advantage policies of 247,849 Healthcare Services Revenue of $183.4 million Adjusted EBITDA* of $2.2 million 96,695 Se

      2/10/25 4:05:00 PM ET
      $SLQT
      Specialty Insurers
      Finance

    $SLQT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by SelectQuote Inc. (Amendment)

      SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)

      1/29/24 3:26:24 PM ET
      $SLQT
      Specialty Insurers
      Finance
    • SEC Form SC 13G/A filed by SelectQuote Inc. (Amendment)

      SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)

      2/14/23 1:42:28 PM ET
      $SLQT
      Specialty Insurers
      Finance
    • SEC Form SC 13G/A filed by SelectQuote Inc. (Amendment)

      SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)

      2/1/23 4:54:05 PM ET
      $SLQT
      Specialty Insurers
      Finance